SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-24-009142 from Ayr Wellness Inc. (AYRWF, AYWWF) (CIK 0001847462) (AYRWF)

Ayr Wellness Inc. (AYRWF, AYWWF) (CIK 0001847462)
Date: Feb. 1, 2024 · CIK: 0001847462 · Accession: 0001104659-24-009142

AI Filing Summary & Sentiment

Date
February 1, 2024
Author
Not clearly detected
Form
CORRESP
Company
Ayr Wellness Inc. (AYRWF, AYWWF) (CIK 0001847462)

Letter

AYR Wellness Inc.

2601 South Bayshore Drive, Suite 900

Miami, Florida 33133

Via Edgar

February 1, 2024

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Joshua Gorsky

Re: AYR Wellness Inc. and Co-Applicants

Application for Qualification of Indenture Under the Trust Indenture Act of 1939 on Form T-3

File No.: 022-29110

Ladies and Gentlemen:

We refer to the Application for Qualification of Indenture Under the Trust Indenture Act of 1939 on Form T-3 (File No. 022-29110) (as amended, the “Form T-3”) of AYR Wellness Inc. (the “Company”), Ayr Wellness Canada Holdings Inc. (the “Issuer”) and the subsidiary guarantors named therein (together with the Company and the Issuer, the “Applicants”), initially filed on November 22, 2023 with the Securities and Exchange Commission (the “Commission”), in connection with the qualification under the Trust Indenture Act of 1939, as amended (the “Act”), of the indenture governing the 13.00% Senior Secured Notes due December 10, 2026 to be issued by the Company’s wholly-owned subsidiary and guaranteed by the Company. On November 22, 2023, the Applicants filed Amendment No. 1 to the above referenced Form T-3 and on November 28, 2023, the Applicants filed Amendment No. 2 to the above referenced Form T-3. Finally, on January 30, 2024, the Applicants filed Amendment No. 3 to the above referenced Form T-3.

In accordance with Section 307(c) of the Act, the Applicants hereby respectfully request the acceleration of the effectiveness of the above referenced Form T-3 so that it may become effective at or prior to 9:00 a.m. (Eastern time) on February 7, 2024 or as soon as reasonably practicable thereafter.

If you have any questions regarding the foregoing, please contact Merritt S. Johnson of Weil, Gotshal & Manges LLP at (212) 310 8280.

Very truly yours,
Ayr Wellness Inc.

Show Raw Text
CORRESP
1
filename1.htm

AYR Wellness Inc.

2601 South Bayshore Drive, Suite 900

Miami, Florida 33133

Via Edgar

February 1, 2024

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Joshua Gorsky

Re:
AYR Wellness Inc. and Co-Applicants

Application for Qualification of Indenture Under the Trust Indenture Act of 1939 on Form T-3

File No.: 022-29110

Ladies and Gentlemen:

We refer to the Application for Qualification of Indenture Under the
Trust Indenture Act of 1939 on Form T-3 (File No. 022-29110) (as amended, the “Form T-3”) of AYR Wellness Inc. (the “Company”),
Ayr Wellness Canada Holdings Inc. (the “Issuer”) and the subsidiary guarantors named therein (together with the Company and
the Issuer, the “Applicants”), initially filed on November 22, 2023 with the Securities and Exchange Commission (the “Commission”),
in connection with the qualification under the Trust Indenture Act of 1939, as amended (the “Act”), of the indenture governing
the 13.00% Senior Secured Notes due December 10, 2026 to be issued by the Company’s wholly-owned subsidiary and guaranteed by the
Company. On November 22, 2023, the Applicants filed Amendment No. 1 to the above referenced Form T-3 and on November 28, 2023, the Applicants
filed Amendment No. 2 to the above referenced Form T-3. Finally, on January 30, 2024, the Applicants filed Amendment No. 3 to the above
referenced Form T-3.

In accordance with Section 307(c) of the Act, the Applicants hereby
respectfully request the acceleration of the effectiveness of the above referenced Form T-3 so that it may become effective at or prior
to 9:00 a.m. (Eastern time) on February 7, 2024 or as soon as reasonably practicable thereafter.

If you have any questions regarding the foregoing, please contact Merritt
S. Johnson of Weil, Gotshal & Manges LLP at (212) 310 8280.

    Very truly yours,

    Ayr Wellness Inc.

    By:
    /s/ Brad Asher

    Name:
    Brad Asher

    Title:
    Chief Financial Officer

[Signature Page Follows]

    1

    Ayr Wellness Canada Holdings Inc.

    By:
    /s/ Brad Asher

    Name:
    Brad Asher

    Title:
    Chief Financial Officer
and Secretary

    242 Cannabis LLC

    AYR NJ LLC

    AYR Wellness Holdings LLC

    DFMMJ Investments LLC d/b/a AYR Cannabis
    Dispensary

    Eskar LLC

    Tahoe Hydroponics Company, LLC

    AYR Ohio LLC

    AYR Wellness NJ LLC

    BP Solutions LLC

    Cannapunch of Nevada LLC

    Cultivauna, LLC d/b/a Levia

    DWC Investments, LLC

    Green Light Holdings, LLC

    Green Light Management, LLC

    Herbal Remedies Dispensaries, LLC

    Kynd-Strainz LLC

    Lemon Aide LLC

    LivFree Wellness LLC

    PA Natural Medicine LLC

    Tahoe-Reno Botanicals, LLC

    Tahoe-Reno Extractions, LLC

    By:
     /s/ Charles Miles

    Name:
    Charles Miles

    Title:
     Manager

    CannTech PA, LLC

    By:
     /s/ Joyce Johnson

    Name:
    Joyce Johnson

    Title:
     Manager and Vice President

    CSAC Acquisition AZ Corp.

    CSAC Acquisition IL II Corp.

    CSAC Acquisition MA Corp.

    CSAC Acquisition NY Corp.

    CSAC Acquisition TX Corp.

    Klymb Project Management, Inc.

    CSAC Acquisition FL Corp.

    CSAC Acquisition IL Corp.

    CSAC Acquisition MA II Corp.

    2

    CSAC Acquisition NV Corp.

    Tahoe Capital Company

    CSAC Acquisition NJ Corp.

    CSAC Acquisition Inc.

    CSAC Holdings Inc.

    CSAC Ohio, LLC

    Mercer Strategies FL, LLC

    Mercer Strategies PA, LLC

    Parker RE MA, LLC

    Parker RE PA, LLC

    Parker Solutions IL, LLC

    Parker Solutions NJ, LLC

    Parker Solutions OH, LLC

    Parker Solutions PA, LLC

    By:
     /s/ Charles Miles

    Name:
    Charles Miles

    Title:
     Director

    CSAC Acquisition Connecticut LLC

    By:
    /s/ Brad Asher

    Name:
    Brad Asher

    Title:
    Manager

    CSAC Acquisition PA Corp.

    CSAC Acquisition PA II Corp.

    By:
    /s/ Paul Fisher

    Name:
    Paul Fisher

    Title:
    Vice President of Sole Member

    DocHouse LLC

    By:
     /s/ Paul Fisher

    Name:
    Paul Fisher

    Title:
    Vice President of Sole Member

    Land of Lincoln Dispensary LLC

    By:
    /s/ Charles Miles

    Name:
    Charles Miles

    Title:
    Vice President and Director of Sole Member

    3

    Mercer Strategies MA, LLC

    Parker Solutions FL, LLC

    By:
    /s/ Charles Miles

    Name:
    Charles Miles

    Title:
    Director of Sole Member

    Parker Solutions MA, LLC

    By:
    /s/ Louis F. Karger

    Name:
    Louis F. Karger

    Title:
    Director of Sole Member

    Sira Naturals, Inc.

    By:
    /s/ Louis F. Karger

    Name:
    Louis F. Karger

    Title:
    Director

    4